Chang‐Qi Zhu

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

Ming‐Sound Tsao, Akira Sakurada, Jean-Claude Cutz et al. · New England Journal of Medicine · 2005 · 1.9K citations

Medicine, Oncology, Pharmacology +14

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

Kerby Shedden, Samir Hanash, Steven A. Eschrich et al. · Nature Medicine · 2008 · 1.2K citations · Full text

Medicine, Molecular Biology, Oncology +17

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

Adam J. Bass, Hideo Watanabe, Craig H. Mermel et al. · Nature Genetics · 2009 · 952 citations · Full text

Medicine, Molecular Biology, Oncology +14

Role of <i>KRAS</i> and <i>EGFR</i> As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21

Chang‐Qi Zhu, Gilda da Cunha Santos, Keyue Ding et al. · Journal of Clinical Oncology · 2008 · 665 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer

Chang‐Qi Zhu, Keyue Ding, Dan Strumpf et al. · Journal of Clinical Oncology · 2010 · 479 citations · Full text

Medicine, Molecular Medicine, Oncology +17